Tech Grace
Pages
Home
Friday, 10 January 2020
FDA-approved stomach cancer drug sends Blueprint Medicines’ stock up before resettling
FDA-approved stomach cancer drug sends Blueprint Medicines’ stock up before resettling
Shares were hovering around $82 as of press time.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment